Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS
No-Receipt date
2016-00032 - 07/01/2016
No-Filing date
20160400018 - 07/01/2016
No-Granting date
3087836 - 05/02/2016
No-EPO application date
11827336.6 - 20/09/2011
No-EPO granting date
2618831 - 06/01/2016
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
2/2016 - 14/04/2016
Expiration date
21/09/2031
Kind of title
Validation of European Patent
Legal status
VALID
Priorities
US201161499994 P22/06/2011/US
US385058 P21/09/2010/US
US201161504616 P05/07/2011/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
C07K 5/097
C07K 5/083
C07K 5/08
C07K 5/062
A61K 38/21
Related Documents
Related Titles
Type
Master title
Related title
[SPC]
20170800039
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
653346
ENANTA PHARMACEUTICALS, INC.
500 ARSENAL STREET
WATERTOWN, MA 02472
UNITED STATES OF AMERICA (USA)
Inventors
Code
Firstname
Surname
1591560
OR, YAT SUN
1591561
MA, JUN
1591562
WANG, GUOQIANG
1591563
LONG, JIANG
1591564
WANG, BIN
Representatives
Code
Firstname
Surname
Address
Town
Zip
3458
ELENI
PAPAKONSTANTINOU "ELENI G. PAPAKOSTANTINOU KAI SYNERGATES, DIKIGORIKI ETAIRIA"
KOUMPARI 2
ATHINA (ATTIKIS)
10674
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
848
EFANGELIA
GIAZITZOGLOU - THOMAIDOU
KOUMPARI 2
ATHINA (ATTIKIS)
10674
GREECE
Owners History
Title Instruments
Date
Operation
Descreption
3/20/2024 12:00:00 AM
Διάφορες Μεταβολές (70004)
ΑΡ.ΠΡΩΤ. 4430/2023 (ΑΡ.ΥΠΟΘ. 4654017/2023) (ΛΙΣΤΑ) ΑΡΣΗ ΚΑΙ ΑΝΤΙΚΑΤΑΣΤΑΣΗ ΑΝΤΙΚΛΗΤΟΥ
Payments history
14 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).